Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone for rapid eye movement sleep behavior disorder
ChiCTR1800017395Phase 4Recruiting
- Sponsor
- Shaanxi Provincial People's Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of idebenone in REM sleep behavior disorder (RBD) (2 arms), sponsored by Shaanxi Provincial People's Hospital. Primary endpoint: Index of rapid eye movement sleep. Started Jan 2019; status: recruiting.
02
Drugs
idebenone
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on ChiCTR1800017395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017395.